Resources
Explore.
The Latest News from Fifth Eye.
FDA grants De Novo classification for innovative analytic technology developed at MCIRCC
Source: MCIRCC Michigan Medicine spin-off company, Fifth Eye, is launching their first product, the Analytic for Hemodynamic Instability (AHI). Read the full article >
FDA grants De Novo classification to Fifth Eye’s continuous hemodynamic status monitoring tool
Source: MobiHealthNews The Analytic for Hemodynamic Instability tool can identify hemodynamic instability with 96% sensitivity and detects stable patients with 85% specificity. Read the full article >
FDA Grants De Novo to ML-based, Real-time Indicator of Patient Deterioration
Source: Fifth Eye Inc. Fifth Eye’s noninvasive tool is the first to provide continuous monitoring of hemodynamic status using a single ECG lead Read the full press release >
Journal Articles And Abstracts Related To AHI
- Belle, A., et al., A Continuous Real-Time Analytic for Predicting Instability in Acute Care Rapid Response Team Activations, 22nd International Conference on Health Analytics, World Academy of Science, Engineering, and Technology, Dec 2020.
- Bassin, B., et al., Detection of hemodynamic status using a novel analytic based solely on a single ECG waveform, Resuscitation Science Symposium 2020, American Heart Association, Nov 2020.
References
- Weil M.H. (2005) Defining Hemodynamic Instability. In: Pinsky M.R., Payen D. (eds) Functional Hemodynamic Monitoring. Update in Intensive Care and Emergency Medicine, vol 42. Springer, Berlin, Heidelberg.
- Hall, John E. 2016. Guyton and Hall Textbook of Medical Physiology. 13th edition. Philadelphia, PA: Elsevier.
- Morozowich, Steven T., and Harish Ramakrishna. 2015. Pharmacologic Agents for Acute Hemodynamic Instability: Recent Advances in the Management of Perioperative Shock- a Systematic Review. Annals of Cardiac Anaesthesia 18 (4): 543–54